Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 11 Thoracic 1 Plasma cell 1 Lymphoid 1 Genitourinary 1 Endocrine 1

Conditions

Prostatic Neoplasms 683 Carcinoma, Renal Cell 225 Urinary Bladder Neoplasms 195 Carcinoma, Transitional Cell 111 Breast Neoplasms 96 Kidney Neoplasms 89 Carcinoma, Non-Small-Cell Lung 82 Neoplasms 81 Melanoma 78 Ovarian Neoplasms 77 Colorectal Neoplasms 68 Neoplasm Metastasis 66 Non-Muscle Invasive Bladder Neoplasms 56 Lung Neoplasms 53 Pancreatic Neoplasms 46 Sarcoma 45 Stomach Neoplasms 42 Endometrial Neoplasms 41 Uterine Cervical Neoplasms 39 Wilms Tumor 33 Adenocarcinoma 33 Esophageal Neoplasms 31 Carcinoma, Hepatocellular 31 Squamous Cell Carcinoma of Head and Neck 30 Triple Negative Breast Neoplasms 29 Head and Neck Neoplasms 27 Testicular Neoplasms 24 Metastatic Castration-resistant Prostate Cancer 24 Neuroblastoma 23 Colonic Neoplasms 23

Interventions

salicylhydroxamic acid 1 Ropivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pain, Postoperative × Genitourinary × 90 days × Clear all

NCT04085237 2026-06-04

ESPB

McMaster University

Phase NA Terminated

Kidney Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡